PMVP.OQ - PMV Pharmaceuticals Inc
Craig Hallum
NEJM Publication Validates Rezatapopt's Significance As A Novel p53 Reactivator For Cancer. Remain BUY Rated With A $4 Price Target.
公司
PMVP.OQ
日期
2026-02-27
分析师
Mr. Albert G. Lowe
页数
6 页
需要登录
请登录后购买研报或生成音频内容。